Clinical Trial Update: A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial to study felzartamab infusions in adults with Immunoglobulin A Nephropathy (IgAN), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Nephropathy

Drugs mentioned

• Felzartamab (felzartamab)

Snippet

Sponsor: Biogen | Conditions: Immunoglobulin A Nephropathy (IgAN) | Phase 3 | Status: RECRUITING